Global 24-hour Ambulatory Blood Pressure Monitoring Device Market Growth 2026-2032
Description
The global 24-hour Ambulatory Blood Pressure Monitoring Device market size is predicted to grow from US$ 263 million in 2025 to US$ 475 million in 2032; it is expected to grow at a CAGR of 9.0% from 2026 to 2032.
A 24-hour Ambulatory Blood Pressure Monitoring (ABPM) Device is a medical device designed to continuously measure a patient’s blood pressure over a full day while they go about their normal activities and sleep. It typically consists of a compact, portable monitor connected to a cuff that inflates at regular intervals to record blood pressure readings. By capturing fluctuations throughout the day and night, a 24-hour ABPM device provides more accurate and comprehensive data compared to single-time clinical measurements, aiding in the diagnosis and management of hypertension, white-coat syndrome, and other cardiovascular conditions.In 2025, global 24-hour Ambulatory Blood Pressure Monitoring Device production reached approximately 424 k units and price is 634 USD/Unit.The average gross profit margin of this product is 30%.
Out-of-office BP management is moving from an “optional test” to “pathway-critical evidence,” and 24-hour monitoring—covering daily activities and sleep—fits naturally into key clinical decisions such as diagnostic confirmation, phenotype recognition, and treatment evaluation. As cardiovascular chronic care extends beyond hospitals and shifts from episodic diagnosis to longitudinal follow-up, 24-hour ABPM integrates well into tiered care, screening programs, outpatient follow-up, and chronic-disease management workflows. Meanwhile, rising demand for standardized reporting and traceable data accelerates the integration of device, software, reporting, and follow-up processes—pushing the product from a standalone tool toward a service-oriented solution.
Competition centers on balancing accuracy, adherence, and interpretability. Arm-size variability, motion artefacts during daily activities, sleep-time disturbance, and inflation/deflation noise can undermine measurement quality and user experience; poor comfort increases data gaps and threatens report credibility. At the industry level, validation practices, quality consistency, and long-term reliability form hard barriers. In parallel, data governance, privacy, interoperability, and cybersecurity requirements raise the bar for transparent algorithms, system integration, and lifecycle operations, while aggressive price competition may squeeze R&D and quality margins.
Demand is shifting from “a single 24-hour test” toward management-oriented use across the patient journey. Clinicians increasingly value nocturnal BP, circadian abnormalities, and masked phenotypes for regimen evaluation and risk stratification. Primary care and health-management organizations prioritize workflow efficiency, patient education, and closed-loop follow-up, favoring products that generate structured reports quickly and support remote data return. Research and real-world applications emphasize completeness, traceability, and cross-device integration. In addition, 24-hour ABPM complements home BP monitoring: home measurement provides frequent long-term trends, while ABPM strengthens the reference standard and nocturnal evidence at key decision points—together advancing out-of-office BP care toward standardization, digitization, and service-based models.
Upstream building blocks can be summarized into cuff/skin-contact materials, pneumatic electromechanical components, and electronics/connectivity modules. Cuff textiles, bladder materials, fasteners, tubing, and connectors shape comfort, durability, and hygiene handling. Miniature pumps, valves, seals, and vibration/noise-damping structures determine inflation/deflation stability, acoustic performance, and long-term reliability—critical to both experience and data quality. Pressure sensors, MCU, memory, power management, and wireless communication modules drive signal integrity, interference resistance, battery performance, and data-return usability. The upgrade trajectory favors better comfort, quieter and more stable pneumatics, lower-power electronics, stronger interoperability, and durable trust barriers built on clinical interpretability and consistent quality.
LP Information, Inc. (LPI) ' newest research report, the “24-hour Ambulatory Blood Pressure Monitoring Device Industry Forecast” looks at past sales and reviews total world 24-hour Ambulatory Blood Pressure Monitoring Device sales in 2025, providing a comprehensive analysis by region and market sector of projected 24-hour Ambulatory Blood Pressure Monitoring Device sales for 2026 through 2032. With 24-hour Ambulatory Blood Pressure Monitoring Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world 24-hour Ambulatory Blood Pressure Monitoring Device industry.
This Insight Report provides a comprehensive analysis of the global 24-hour Ambulatory Blood Pressure Monitoring Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on 24-hour Ambulatory Blood Pressure Monitoring Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global 24-hour Ambulatory Blood Pressure Monitoring Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for 24-hour Ambulatory Blood Pressure Monitoring Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global 24-hour Ambulatory Blood Pressure Monitoring Device.
This report presents a comprehensive overview, market shares, and growth opportunities of 24-hour Ambulatory Blood Pressure Monitoring Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Ordinary ABPM
Mobile-based ABPM
Segmentation by Product Form:
Recorder + Separate Cuff
Cuff-integrated Wearable
Segmentation by Sales Channel:
Online
Offline
Segmentation by Application:
Hospital
Clinic
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Baxter
SunTech Medical(Halma)
A&D
Spacelabs Healthcare
Schiller
Bosch + Sohn
Microlife
Vasomedical
Meditech
Riester
Mindray
Suzuken
HINGMED
Kang Medical
Bi-biomed
BORSAM
raycome
CONTEC
Key Questions Addressed in this Report
What is the 10-year outlook for the global 24-hour Ambulatory Blood Pressure Monitoring Device market?
What factors are driving 24-hour Ambulatory Blood Pressure Monitoring Device market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do 24-hour Ambulatory Blood Pressure Monitoring Device market opportunities vary by end market size?
How does 24-hour Ambulatory Blood Pressure Monitoring Device break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
A 24-hour Ambulatory Blood Pressure Monitoring (ABPM) Device is a medical device designed to continuously measure a patient’s blood pressure over a full day while they go about their normal activities and sleep. It typically consists of a compact, portable monitor connected to a cuff that inflates at regular intervals to record blood pressure readings. By capturing fluctuations throughout the day and night, a 24-hour ABPM device provides more accurate and comprehensive data compared to single-time clinical measurements, aiding in the diagnosis and management of hypertension, white-coat syndrome, and other cardiovascular conditions.In 2025, global 24-hour Ambulatory Blood Pressure Monitoring Device production reached approximately 424 k units and price is 634 USD/Unit.The average gross profit margin of this product is 30%.
Out-of-office BP management is moving from an “optional test” to “pathway-critical evidence,” and 24-hour monitoring—covering daily activities and sleep—fits naturally into key clinical decisions such as diagnostic confirmation, phenotype recognition, and treatment evaluation. As cardiovascular chronic care extends beyond hospitals and shifts from episodic diagnosis to longitudinal follow-up, 24-hour ABPM integrates well into tiered care, screening programs, outpatient follow-up, and chronic-disease management workflows. Meanwhile, rising demand for standardized reporting and traceable data accelerates the integration of device, software, reporting, and follow-up processes—pushing the product from a standalone tool toward a service-oriented solution.
Competition centers on balancing accuracy, adherence, and interpretability. Arm-size variability, motion artefacts during daily activities, sleep-time disturbance, and inflation/deflation noise can undermine measurement quality and user experience; poor comfort increases data gaps and threatens report credibility. At the industry level, validation practices, quality consistency, and long-term reliability form hard barriers. In parallel, data governance, privacy, interoperability, and cybersecurity requirements raise the bar for transparent algorithms, system integration, and lifecycle operations, while aggressive price competition may squeeze R&D and quality margins.
Demand is shifting from “a single 24-hour test” toward management-oriented use across the patient journey. Clinicians increasingly value nocturnal BP, circadian abnormalities, and masked phenotypes for regimen evaluation and risk stratification. Primary care and health-management organizations prioritize workflow efficiency, patient education, and closed-loop follow-up, favoring products that generate structured reports quickly and support remote data return. Research and real-world applications emphasize completeness, traceability, and cross-device integration. In addition, 24-hour ABPM complements home BP monitoring: home measurement provides frequent long-term trends, while ABPM strengthens the reference standard and nocturnal evidence at key decision points—together advancing out-of-office BP care toward standardization, digitization, and service-based models.
Upstream building blocks can be summarized into cuff/skin-contact materials, pneumatic electromechanical components, and electronics/connectivity modules. Cuff textiles, bladder materials, fasteners, tubing, and connectors shape comfort, durability, and hygiene handling. Miniature pumps, valves, seals, and vibration/noise-damping structures determine inflation/deflation stability, acoustic performance, and long-term reliability—critical to both experience and data quality. Pressure sensors, MCU, memory, power management, and wireless communication modules drive signal integrity, interference resistance, battery performance, and data-return usability. The upgrade trajectory favors better comfort, quieter and more stable pneumatics, lower-power electronics, stronger interoperability, and durable trust barriers built on clinical interpretability and consistent quality.
LP Information, Inc. (LPI) ' newest research report, the “24-hour Ambulatory Blood Pressure Monitoring Device Industry Forecast” looks at past sales and reviews total world 24-hour Ambulatory Blood Pressure Monitoring Device sales in 2025, providing a comprehensive analysis by region and market sector of projected 24-hour Ambulatory Blood Pressure Monitoring Device sales for 2026 through 2032. With 24-hour Ambulatory Blood Pressure Monitoring Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world 24-hour Ambulatory Blood Pressure Monitoring Device industry.
This Insight Report provides a comprehensive analysis of the global 24-hour Ambulatory Blood Pressure Monitoring Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on 24-hour Ambulatory Blood Pressure Monitoring Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global 24-hour Ambulatory Blood Pressure Monitoring Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for 24-hour Ambulatory Blood Pressure Monitoring Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global 24-hour Ambulatory Blood Pressure Monitoring Device.
This report presents a comprehensive overview, market shares, and growth opportunities of 24-hour Ambulatory Blood Pressure Monitoring Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Ordinary ABPM
Mobile-based ABPM
Segmentation by Product Form:
Recorder + Separate Cuff
Cuff-integrated Wearable
Segmentation by Sales Channel:
Online
Offline
Segmentation by Application:
Hospital
Clinic
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Baxter
SunTech Medical(Halma)
A&D
Spacelabs Healthcare
Schiller
Bosch + Sohn
Microlife
Vasomedical
Meditech
Riester
Mindray
Suzuken
HINGMED
Kang Medical
Bi-biomed
BORSAM
raycome
CONTEC
Key Questions Addressed in this Report
What is the 10-year outlook for the global 24-hour Ambulatory Blood Pressure Monitoring Device market?
What factors are driving 24-hour Ambulatory Blood Pressure Monitoring Device market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do 24-hour Ambulatory Blood Pressure Monitoring Device market opportunities vary by end market size?
How does 24-hour Ambulatory Blood Pressure Monitoring Device break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
135 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for 24-hour Ambulatory Blood Pressure Monitoring Device by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for 24-hour Ambulatory Blood Pressure Monitoring Device by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
